• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肠杆菌对新型喹诺酮类药物的耐药性]

[Resistance to new quinolones among the enterobacteria].

作者信息

Liassine N, Chelfi A, Rahal K

机构信息

Laboratoire de bactériologie médicale, Institut Pasteur d'Algérie.

出版信息

Arch Inst Pasteur Alger. 1992;58:85-94.

PMID:1309147
Abstract

We report the isolation of 10 strains of enterobacteriaceae with a new quinolone's resistance. This resistance was detected by a diminution of inhibition's diameter around the disk of pefloxacin , and confirmed by the determination of Minimal Inhibiting Concentrations (M.I.C.). These strains, moreover multiresistant to multiple antibiotics, were isolated from patient's urines with repetitive urinary tract infections (paraplegics, lithiasic patients). None of this patients was treated by new quinolones. The incorrect use of old quinolones is probably responsible for the selection of this new quinolone's resistance.

摘要

我们报告分离出10株对新型喹诺酮耐药的肠杆菌科细菌。这种耐药性通过培氟沙星纸片周围抑菌圈直径的减小来检测,并通过最低抑菌浓度(M.I.C.)的测定得以确认。此外,这些菌株对多种抗生素多重耐药,是从患有复发性尿路感染的患者尿液中分离出来的(截瘫患者、结石患者)。这些患者均未接受新型喹诺酮类药物治疗。旧喹诺酮类药物的不当使用可能是导致这种新型喹诺酮耐药性产生的原因。

相似文献

1
[Resistance to new quinolones among the enterobacteria].[肠杆菌对新型喹诺酮类药物的耐药性]
Arch Inst Pasteur Alger. 1992;58:85-94.
2
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.培氟沙星与其他五种喹诺酮类药物对耐萘啶酸变形杆菌属细菌的体外活性比较。
Chemioterapia. 1988 Oct;7(5):287-91.
3
[The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections].
Mikrobiyol Bul. 1988;22(3):187-92.
4
[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].诺氟沙星、氧氟沙星和培氟沙星对320株对萘啶酸和头孢菌素耐药及不耐药的革兰氏阴性杆菌的细菌学活性比较
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):564-8.
5
[Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].根据对萘啶酸和培氟沙星的耐药表型研究诺氟沙星、氧氟沙星和环丙沙星的抗菌活性
Pathol Biol (Paris). 1990 May;38(5):376-84.
6
[Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].4种喹诺酮类药物(萘啶酸、培氟沙星、诺氟沙星、氧氟沙星)对13种细菌的体外比较活性
Arch Inst Pasteur Alger. 1992;58:41-84.
7
Biphasic kinetics of bacterial killing by quinolones.
J Antimicrob Chemother. 1991 Mar;27(3):319-27. doi: 10.1093/jac/27.3.319.
8
Plasmid "curing" by some recently synthetized 4-quinolone compounds.
Chemioterapia. 1988 Oct;7(5):292-4.
9
[Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].培氟沙星(1589 RB)、萘啶酸和氟甲喹抗菌活性的比较(作者译)
Pathol Biol (Paris). 1982 Jun;30(6):394-7.
10
[Must pefloxacin and norfloxacin be studied separately against bacteria isolated from urinary tract infections by the API-ATB method?].[是否必须通过API-ATB方法分别研究培氟沙星和诺氟沙星对从尿路感染中分离出的细菌的作用?]
Pathol Biol (Paris). 1995 Apr;43(4):294-9.